Maryll E. Geherty
6Patents
1h-index
16Co-inventors
40Inventor score
Filing activity: Mar 15, 2018 → Nov 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10894796B2 | MK2 inhibitors, synthesis thereof, and intermediates thereto | Chemistry; Metallurgy | 8 | Active |
| US11655257B2 | MK2 inhibitors, synthesis thereof, and intermediates thereto | Chemistry; Metallurgy | 1 | Active |
| US10590136B2 | Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Human Necessities | 0 | Active |
| US11505522B2 | Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate | Emerging Cross-Sectional Technologies | 0 | Active |
| US10717703B2 | Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate | Emerging Cross-Sectional Technologies | 0 | Active |
| US11912644B2 | Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.